Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05599490 · ClinicalTrials.gov registry record · NA

Brain Enhancement Training Towards Elders Resilience to Aging, Phase IIB

A NA study of Age-related Cognitive Decline, sponsored by Posit Science Corporation.

Completed
Registry status
NA
Development phase
135
Enrollment target
2
Study locations

NCT05599490 is a NA study of Age-related Cognitive Decline that has completed, run by Posit Science Corporation. The registered enrollment target is 135 participants, below the 1,120-participant average among 10 other Age-related Cognitive Decline trials with a reported enrollment target (88% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05599490, a NA study of Age-related Cognitive Decline, has completed, sponsored by Posit Science Corporation.

COMPLETED
Registry status
NA
Development phase
135 participants
Enrollment target
2
Study locations

Study Summary

This study aims to examine the longer-term benefits of a novel, neuroplasticity-based, computerized and web-deliverable training program (PACR-CT) five years from the initial 10 weeks of training from our Phase II study - Protocol #: PSC-0605-17 (Aim 1) and test the interactive effect of previous training and 10 weeks of booster training (Aim 2). Both the study and the software being investigated meet the criteria of Non-Significant Risk.

Interventions

  • OTHER Computerized Plasticity-Based Adaptive Cognitive Training

Study Locations (2)

Iowa

  • University of Iowa - Iowa City

Texas

  • University of Texas at Dallas - Dallas

Trial Details

FieldValue
Enrollment Target 135 participants
Start Date 2023-12-14
Est. Completion 2026-01-28
Phase NA

Sponsor

Posit Science Corporation

30 total trials

What the Registry Record Tells You About NCT05599490

The ClinicalTrials.gov registry entry for NCT05599490 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 135 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,120-participant average among 10 other Age-related Cognitive Decline trials with a reported enrollment target (88% lower). The listed sponsor is Posit Science Corporation, which has 30 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Age-related Cognitive Decline appearing as the primary indexed condition, and to 1 intervention - of which Computerized Plasticity-Based Adaptive Cognitive Training is the first listed.

NCT05599490 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Iowa, Texas.

Frequently Asked Questions

What is clinical trial NCT05599490 about?

NCT05599490 is a clinical study titled "Brain Enhancement Training Towards Elders Resilience to Aging, Phase IIB". This study aims to examine the longer-term benefits of a novel, neuroplasticity-based, computerized and web-deliverable training program (PACR-CT) five years from the initial 10 weeks of training from our Phase II study - Protocol #: PSC-0605-17 (Aim 1) and test the interactive effect of previous tr...

What is the current status of trial NCT05599490?

This trial is currently completed. It is a NA study. The enrollment target is 135 participants. The study started on 2023-12-14. Estimated completion is 2026-01-28.

What conditions does trial NCT05599490 study?

This clinical trial studies the following conditions: Age-related Cognitive Decline.

What interventions are being tested in trial NCT05599490?

The interventions under investigation include: Computerized Plasticity-Based Adaptive Cognitive Training (OTHER).

Who is sponsoring clinical trial NCT05599490?

This trial is sponsored by Posit Science Corporation, which has 30 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05599490 being conducted?

This trial has 2 study locations across Iowa, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Age-related Cognitive Decline

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.